| Cat. No. | Product Name | Inquiry |
|---|---|---|
| X24-07-ZQ148 | HCV protease inhibitor JTK-853, Purity ≥98% | |
| X24-07-ZQ155 | HCV protease inhibitor HCV-IN-3, Purity ≥98% | |
| X24-07-ZQ157 | HCV protease inhibitor Merimepodib, Purity ≥98% | |
| X24-07-ZQ158 | HCV protease inhibitor PSI-352938, Purity ≥98% | |
| X24-07-ZQ163 | HCV protease inhibitor Beclabuvir, Purity ≥98% | |
| X24-07-ZQ164 | HCV protease inhibitor PSI-7976, Purity ≥98% | |
| X24-07-ZQ165 | HCV protease inhibitor Sofosbuvir impurity C, Purity ≥98% | |
| X24-07-ZQ166 | HCV protease inhibitor Sofosbuvir impurity A, Purity ≥98% | |
| X24-07-ZQ169 | HCV protease inhibitor NM107, Purity ≥98% | |
| X24-07-ZQ171 | HCV protease inhibitor PSI-6206 13CD3, Purity ≥98% | |
| X24-07-ZQ178 | HCV protease inhibitor HZ-1157, Purity ≥98% | |
| X24-07-ZQ184 | HCV protease inhibitor BLT-1, Purity ≥98% | |
| X24-07-ZQ850 | HCV protease inhibitor EIDD-1931, Purity ≥98% |
About Us
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.